Skip to content
Learn Motion
ExploreHow it worksMembership
Log in
Learn Motion

AI Antibody Design vs Human Design: A Conceptual Overview

1Why Antibody Design Matters2How Humans Design Antibodies3How AI Learns to Design Antibodies4Comparing AI and Human Design5Evidence, Limits, and Open Questions
How Humans Design Antibodies

How Display Selection Pulls Binders Out of a Library

2 / 4
Follow one particle through the animation. At the start, the library is a mixture — most particles display variants that do not recognize the target, and a few display variants that do. Each particle also carries the gene for the variant on its surface, which is why a binder can be identified later. When the library meets the immobilized target, only the matching variants stick. The wash step is the selection event: everything that did not bind is removed, and the population that remains is enriched. Then the bound particles are eluted and amplified, which regenerates a library — but a library that is now biased toward binders. Watch the composition change across rounds. That shift is the whole method: the experiment imposes a binding criterion on an enormous library at once, and only variants that satisfy it survive.
0:00 / 0:00

Display-based selection solves a practical problem: if you have a library of billions of antibody variants, how do you find the few that bind your target, and how do you know which gene made them?

The answer is to keep each variant physically attached to its own genetic instructions. In phage display, each antibody variant is displayed on the coat of a bacteriophage particle, and the gene encoding that variant is packaged inside the same particle. The variant and its blueprint are never separated.

Selection then proceeds in rounds. The library is applied to the target antigen, which has been immobilized on a surface such as the well of a plate. Variants that bind stay attached; variants that do not bind are washed away. The bound phages are eluted, and because they still carry their genes, they can be used to infect bacteria and be amplified into a new, enriched library.

One round rarely produces a pure binder. Each round increases the proportion of target-binding variants, so the process is repeated — typically two to five rounds — until the population is dominated by binders. Stringency can be increased between rounds, for example by lowering the amount of target or adding competing antigen, which favors variants with higher affinity.

After the final round, individual clones are picked and sequenced, and their antibodies are produced and tested. The key conceptual point is that selection does the searching, not the scientist: the experiment applies a binding criterion to an enormous library at once, and only variants that satisfy it survive.

References

  1. [1]Phage display — Nobel Prize popular informationnobelprize.org
Previous2 / 4Next

Learn Motion

Generate a course. Learn it properly.

Operated by Wuhan Daoyin Technology Co., Ltd.

Contact: [email protected]
Privacy PolicyTerms of Service

© 2026 Learn Motion